Isoflavones and Postmenopausal Bone Health: A Viable Alternative to Estrogen Therapy?
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The rapidly growing postmenopausal population in the United States, and this population's high incidence and prevalence of osteoporosis and related morbidity and mortality herald an enormous public health burden for the coming decades. Estrogen replacement has been the mainstay of therapy for the prevention and treatment of osteoporosis in this estrogen-deficient population. However, long-term compliance with estrogen therapy generally is poor, and there are numerous concerns regarding its safety. The phytoestrogens are nonsteroidal plant-derived compounds that exhibit estrogenic activity at several sites. The isoflavones are one class of phytoestrogens derived largely from soy-based products. International popularity for menopausal therapy regimens containing isoflavones is growing rapidly. In this article, we review the existing data on isoflavones and postmenopausal bone health. DESIGN: A review of interventional trials examining isoflavones and bone in animals and humans. RESULTS: The data point to a reduction in bone resorption resulting from isoflavone/ipriflavone intake. CONCLUSIONS: The data on naturally occurring isoflavones are very limited but suggest that including them in the diet results in reduction in bone resorption caused by estrogen deficiency. The extensive data on ipriflavone, a synthetic isoflavone derivative, suggest that it is a useful and safe alternative to estrogen therapy in treating existing low bone mass or osteoporosis in postmenopausal women. Further studies are warranted to examine the utility of ipriflavone as a preventive agent, as well as the clinical efficacy of the naturally occurring isoflavones.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Despite these claims, the only beneficial effect of methoxyisoflavone that has been reported in multiple research publications and U.S. patents is the benefits of reduced bone resorption and bone loss prevention [2-4].”
From Effects of methoxyisoflavone, ecdysterone, and sulfo-polysaccharide supplementation on training adaptations in resistance-trained males (2006) · cites this paper as [4]
Citations
Cites
Stampfer, M. J., & Colditz, G. A. (1991) · Preventive Medicine · doi:10.1016/0091-7435(91)90006-p · Cited by 1,600
The worldwide problem of osteoporosis: Insights afforded by epidemiology
Riggs, B. L., & Melton, L. J. (1995) · Bone · doi:10.1016/8756-3282(95)00258-4 · Cited by 1,404
Cummings, S. R. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.149.11.2445 · Cited by 699
Rapid HPLC Analysis of Dietary Phytoestrogens from Legumes and from Human Urine
Franke, A. A., Custer, L. J., Cerna, C. M., & Narala, K. (1995) · Experimental Biology and Medicine · doi:10.3181/00379727-208-43826 · Cited by 306
Hormone replacement therapy and risk of hip fracture: population based case-control study
Michaëlsson, K., Baron, J. A., Farahmand, B. Y., Johnell, O., Magnusson, C., Persson, P.-G., Persson, I., & Ljunghall, S. (1998) · BMJ · doi:10.1136/bmj.316.7148.1858 · Cited by 256
Biomechanics of Osteoporosis and Vertebral Fracture
Myers, E. R., & Wilson, S. E. (1997) · Spine · doi:10.1097/00007632-199712151-00005 · Cited by 239
Riggs, B. L., Melton, L. J., & O'Fallon, W. M. (1996) · Bone · doi:10.1016/8756-3282(95)00502-1 · Cited by 183
ISHIDA, H., UESUGI, T., HIRAI, K., TODA, T., NUKAYA, H., YOKOTSUKA, K., & TSUJI, K. (1998) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.21.62 · Cited by 174
Setchell, K. D. R., Welsh, M. B., & Lim, C. K. (1987) · Journal of Chromatography A · doi:10.1016/s0021-9673(01)94608-4 · Cited by 160
Genistin (an Isoflavone Glucoside) and its Aglucone, Genistein, from Soybeans
Walter, E. D. (1941) · Journal of the American Chemical Society · doi:10.1021/ja01857a013 · Cited by 144
Research works printed but not linked: 6
- Cummings, 1989, Ann Intern Med, 149, 244, 10.1001/archinte.1989.00390110045010 · doi:10.1001/archinte.1989.00390110045010 · Paper page
- Masi, 1997, Int J Fertil Women Med, 42, 245
- Maleka, 1995, Environ Health Perspect, 103, 123
- Moule, 1963, Anim Breed Abstr, 31, 139
- Walters, 1982, Effect of a lignan (HPMF) on RNA synthesis in the rat Uterus, J Reprod Fertil, 66, 379
- Kuiper, 1998, Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor Endocrinology, 139, 4252
Cited by
Papaioannou, A., Morin, S., Cheung, A. M., Atkinson, S., Brown, J. P., Feldman, S., Hanley, D. A., Hodsman, A., Jamal, S. A., Kaiser, S. M., et al. (2010) · Canadian Medical Association Journal · doi:10.1503/cmaj.100771 · Cited by 1,749
Setchell, K. D. R., Brown, N. M., & Lydeking-Olsen, E. (2002) · The Journal of Nutrition · doi:10.1093/jn/132.12.3577 · Cited by 1,209
Bone Mineral Density Thresholds for Pharmacological Intervention to Prevent Fractures
Siris, E. S., Chen, Y.-T., Abbott, T. A., Barrett-Connor, E., Miller, P. D., Wehren, L. E., & Berger, M. L. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.10.1108 · Cited by 1,093
Nutrition in Bone Health Revisited: A Story Beyond Calcium
Ilich, J. Z., & Kerstetter, J. E. (2000) · Journal of the American College of Nutrition · doi:10.1080/07315724.2000.10718070 · Cited by 509
“A recent review of interventional JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION 727 clinical trials with isoflavones/ipriflavone in animals and humans by Scheiber and Rebar [269] suggests that they have antiresorptive properties and are safe alternatives to estrogen therapy in postmenopausal osteoporosis.”
BackgroundPhytoestrogens: a review of the present state of research
Ososki, A. L., & Kennelly, E. J. (2003) · Phytotherapy Research · doi:10.1002/ptr.1364 · Cited by 479
“Ipriflavone, a synthetic isoflavone derivative (7-isopropoxy-isoflavone), has been used extensively in animal and human studies to evaluate bone health and phytoestrogens with beneficial results (Scheiber and Rebar, 1999).”
Background
Metadata
- Authors
- Scheiber, M. D., & Rebar, R. W.
- Affiliations
- University of Cincinnati (US)
- ORCID
- Rebar, Robert W.
- Venue
- Menopause
- Published
- 1999
- Volume
- 6
- Issue
- 3
- Pages
- 233-241
- ISSN
- 1072-3714 (ISSN-L)
- OpenAlex
- W2329583146
- Semantic Scholar
- 78596f637d0da79fc474bd6cfaab61cb9d877da5
- Cited by
- 74
- References
- 17
- Citations by year
- 2025: 1 · 2023: 1 · 2020: 1 · 2016: 1 · 2014: 2 · 2013: 4 · 2012: 2
- FWCI
- 4.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Menopause The Journal of The North American Menopause Society (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Phytoestrogen effects and research
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- isoflavones, phytoestrogens, postmenopausal osteoporosis, bone health, estrogen deficiency, estrogen replacement therapy, ipriflavone, bone resorption, soy products, hormone replacement therapy
- MeSH terms
- Aged, Animals, Clinical Trials as Topic, Disease Models, Animal, Female, Humans, Isoflavones, Middle Aged, Rabbits, Sensitivity and Specificity, Bone Density, Osteoporosis, Postmenopausal, Estrogen Replacement Therapy, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Isoflavones and Postmenopausal Bone Health: A Viable Alternative to Estrogen Therapy? https://app.cochat.ai/papers/10.1097/00042192-199906030-00010
- The paper
- Scheiber, M. D., & Rebar, R. W. (1999). Isoflavones and Postmenopausal Bone Health: A Viable Alternative to Estrogen Therapy? Menopause. https://doi.org/10.1097/00042192-199906030-00010
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.